SCIEX and Evosep will collaborate to provide robust, high-throughput proteomics workflows

Today, SCIEX and Evosep announce an agreement to co-market products together to improve robust, high-throughput proteomics workflows for precision medicine. SCIEX and Evosep plan to use the ZenoTOF 7600 system and the Evosep One to engage with several joint customers to better allow them to develop and validate proteomics-based assays.

SCIEX and Evosep will collaborate to provide robust, high-throughput proteomics workflows

Evosep One is a chromatography system that delivers fast, sensitive and robust proteomic analysis of clinical samples, while supporting connections to a wide range of mass spectrometers. Image Credit: SCIEX

Mass spectrometry (MS)-based proteomics has become a central technology in biological research and it is now promising to become equally powerful for precision medicine and large scale multi-omics studies. Proteomics was challenged by the speed and robustness necessary for precision medicine and biomarker discovery, but with recent advances in sample preparation, chromatography, and mass spectrometry, accurate proteome quantitation in high throughput mode for thousands of samples is now possible.

The ZenoTOF 7600 system with its enhanced speed of acquisition and sensitivity improvements can detect and quantify up to 40% more proteins than our previous systems and EAD fragmentation delivers new capabilities for post-translational modifications – an important but challenging area in biomarker research. The Evosep One adds even more sensitivity and higher throughput to be the perfect match for translational proteomics on a very large scale.”

Dr. Jose Castro-Perez, Senior Director of Accurate Mass Product Management at SCIEX

The Evosep One separation solution fits perfectly with the focused applications developed by SCIEX. It can provide one to two orders of magnitude better sensitivity with its low-flow rate methods while still being extremely robust and easy to use.”

Dr Nicolai Bache, Head of Application, Evosep elaborates

In the future, the companies hope to broaden the collaboration to more applications and instrument platforms.

To learn more about the ZenoTOF 7600 system, see here. To learn more about the Evosep One, see here.

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    SCIEX. (2021, November 05). SCIEX and Evosep will collaborate to provide robust, high-throughput proteomics workflows. AZoLifeSciences. Retrieved on December 03, 2021 from https://www.azolifesciences.com/news/20211105/SCIEX-and-Evosep-will-collaborate-to-provide-robust-high-throughput-proteomics-workflows.aspx.

  • MLA

    SCIEX. "SCIEX and Evosep will collaborate to provide robust, high-throughput proteomics workflows". AZoLifeSciences. 03 December 2021. <https://www.azolifesciences.com/news/20211105/SCIEX-and-Evosep-will-collaborate-to-provide-robust-high-throughput-proteomics-workflows.aspx>.

  • Chicago

    SCIEX. "SCIEX and Evosep will collaborate to provide robust, high-throughput proteomics workflows". AZoLifeSciences. https://www.azolifesciences.com/news/20211105/SCIEX-and-Evosep-will-collaborate-to-provide-robust-high-throughput-proteomics-workflows.aspx. (accessed December 03, 2021).

  • Harvard

    SCIEX. 2021. SCIEX and Evosep will collaborate to provide robust, high-throughput proteomics workflows. AZoLifeSciences, viewed 03 December 2021, https://www.azolifesciences.com/news/20211105/SCIEX-and-Evosep-will-collaborate-to-provide-robust-high-throughput-proteomics-workflows.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.